Navigation Links
Aspirin may help men with prostate cancer live longer, study suggests
Date:8/28/2012

DALLAS Aug. 28, 2012 Men who have been treated for prostate cancer, either with surgery or radiation, could benefit from taking aspirin regularly, says a new study that includes a researcher at UT Southwestern Medical Center.

Taking aspirin is associated with a lower risk of death from prostate cancer, especially in men with high risk disease, according to a multicenter study published in today's issue of the Journal of Clinical Oncology. Dr. Kevin Choe, assistant professor of radiation oncology at UT Southwestern, is first author of the paper.

Preclinical studies have shown that aspirin and other anticoagulation medications may inhibit cancer growth and metastasis, but clinical data have been limited previously. The study looked at almost 6,000 men in the Cancer of the Prostate Strategic Urologic Research Endeavor (CaPSURE) database who had prostate cancer treated with surgery or radiotherapy.

About 2,200 of the men involved 37 percent were receiving anticoagulants (warfarin, clopidogrel, enoxaparin, and/or aspirin). The risk of death from prostate cancer was compared between those taking anticoagulants and those who were not.

The findings demonstrated that 10-year mortality from prostate cancer was significantly lower in the group taking anticoagulants, compared to the non-anticoagulant group 3 percent versus 8 percent, respectively. The risks of cancer recurrence and bone metastasis also were significantly lower. Further analysis suggested that this benefit was primarily derived from taking aspirin, as opposed to other types of anticoagulants.

The suggestion that aspirin, a frequently prescribed and relatively well-tolerated medication, may improve outcomes in prostate cancer is of particular interest, Dr. Choe said, since prostate cancer is the most common non-skin cancer among men and the second-leading cancer killer in the U.S.

"The results from this study suggest that aspirin prevents the growth of tumor cells in prostate cancer, especially in high-risk prostate cancer, for which we do not have a very good treatment currently," Dr. Choe said. "But we need to better understand the optimal use of aspirin before routinely recommending it to all prostate cancer patients."


'/>"/>

Contact: Alex Lyda
alex.lyda@utsouthwestern.edu
214-648-3404
UT Southwestern Medical Center
Source:Eurekalert

Related medicine news :

1. Daily Aspirin May Help Fight Prostate Cancer, But Not Breast Cancer
2. Daily Aspirin May Cut Cancer Deaths, Another Study Finds
3. Daily aspirin usage associated with lower cancer mortality
4. Study adds to evidence daily aspirin linked to lower cancer mortality
5. Aspirin protects against Barretts esophagus
6. Some Diabetics May Not Benefit From Daily Aspirin
7. Aspirin as Effective as Warfarin for Heart Failure: Study
8. Report says new evidence could tip the balance in aspirin cancer prevention care
9. Race May Affect Quality of Prostate Cancer Surgical Care
10. Breast Cancer Drug Might Help Men on Prostate Cancer Therapy
11. Reducing the side effects of treatment for prostate cancer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/20/2020)... ... 2020 , ... Millennial women are flocking to cosmetic surgeons like Dr. Richard ... treatments to achieve “ Rich Girl Face .” In fact, Glamour magazine called it ... into 2020. It’s a look inspired by the signature bee-stung lips, smooth skin, lifted ...
(Date:2/19/2020)... ... February 19, 2020 , ... Spaulding Youth Center is ... the Doug Flutie, Jr. Foundation for Autism. The grant will directly support Spaulding’s ... physical fitness program will include the hiring of a fitness professional who will ...
(Date:2/19/2020)... ... February 19, 2020 , ... The ... deadline for its new Lifestyle Medicine Residency Curriculum (LMRC). The curriculum is the ... medical residency programs. Driven by resident involvement, the curriculum has included residents ...
(Date:2/19/2020)... ... 19, 2020 , ... MedTech IGNITE Expands Steering Committee, Faculty ... in 2020 Cohort , The Massachusetts Medical Device Industry Council ( MassMEDIC ) ... from startup founders and CEOs to participate in the 2020 IGNITE Cohort. ...
(Date:2/19/2020)... ... February 19, 2020 , ... BPM+ ... delivery, announced that it will participate in the HIMSS20 Global Health ... will engage healthcare professionals and other stakeholders at HIMSS20 – the largest global ...
Breaking Medicine News(10 mins):
(Date:2/21/2020)... ... , ... Nationwide jails are seeing higher rates of incarcerated people with serious ... is no more likely to commit a crime than anyone else, when they do, ... They may be experiencing symptoms that lead to these types of crimes. Statistics show ...
(Date:2/21/2020)... ... February 21, 2020 , ... The business of healthcare ... keeping up with industry trends and ensuring patients digital and physical safety, there are ... wayside. , That’s why MaintenX International’s is excited to provide their insights on ...
(Date:2/20/2020)... ... February 20, 2020 , ... ... full-service provider of compassionate, in-home senior care from trained and knowledgeable Amada caregivers. ... highly personalized approach to meeting every client’s unique needs, preferences and desires, all ...
Breaking Medicine Technology: